Annual review of cancer biology

· 1 paper in corpus
2024
doi:10.1146/annurev-cancerbio-061223-094639 ·PMID:40491864

Gene fusions are well-known drivers of cancer and are potent targets for molecular therapy. An emerging spectrum of human tumors harbors recurrent and pathognomonic gene fusions that involve the transcriptional coactivator YAP1 (which encod…